4//SEC Filing
Grant Jeremy T 4
Accession 0001415889-25-014005
CIK 0001583107other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 7:10 PM ET
Size
7.2 KB
Accession
0001415889-25-014005
Insider Transaction Report
Form 4
Grant Jeremy T
Director
Transactions
- Award
Share Option (Right to Buy)
2025-05-19+24,258→ 24,258 totalExercise: $9.39Exp: 2035-05-18→ Ordinary Shares (24,258 underlying) - Award
Ordinary Shares
2025-05-19+10,649→ 32,954 total
Footnotes (1)
- [F1]This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0002004368
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 7:10 PM ET
- Size
- 7.2 KB